Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

The United States market has remained flat over the past week but has seen an 8.5% increase over the past year, with earnings projected to grow by 14% annually. In this context, identifying ...

Long-term treatment with Duvyzat (givinostat) may help delay the loss of walking ability and lessen the decline in lung ...

Cambridge, USA-based RNS specialist Wave Life Sciences (Nasdaq: WVE) has announced positive data from the Phase II FORWARD-53 trial of WVE-N531, which is an exon skipping oligonucleotide being ...

Coming Together for a Cure partnered with Cariloop to give families free access to its caregiver support platform.

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...

Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...

Traditionally, stock market corrections have been the perfect time for long-term-minded investors with ample cash on hand to ...

Santhera Pharmaceuticals to share latest on rollout of AGAMREE and future strategic priorities: Pratteln, Switzerland Thursday, March 27, 2025, 13:00 Hrs [IST] Santhera Pharmaceut ...